Evaluation of the Nutritional Status in Institutionalized Children and its Relationship to the Development of

M L Nunes1, G C Teixeira2, I Fabris2

  • 1a Division of Neurology , São Lucas University Hospital and School of Medicine-Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) , Av. Ipiranga 6690 #322, Porto Alegre , RS , Brazil 90610-000.

Insights

This study investigated if malnutrition causes epilepsy in children. While malnourished children had more epilepsy cases, the link was not statistically significant, suggesting other factors are involved.

Area of Science:

  • Pediatrics
  • Neurology
  • Public Health

Background:

  • Malnutrition remains a major cause of infant mortality globally.
  • Childhood epilepsy is prevalent, with a suspected but unproven link to malnutrition.
  • Early malnutrition risk factors include poor perinatal care and low birth weight.

Purpose of the Study:

  • To investigate the potential causal relationship between malnutrition and epilepsy in human infants.
  • To analyze anthropometric and medical data to assess malnutrition's impact on epilepsy development.

Main Methods:

  • Retrospective review of anthropometric and medical files of infants in a governmental institution.
  • Defined malnutrition as height/weight below two standard deviations from NCHS growth charts.
  • Included 243 children: 101 malnourished and 133 nourished.

Main Results:

  • Malnutrition showed a predominance in girls (49%).
  • A comorbidity of malnutrition and neurological disorders was observed.
  • Epilepsy cases were more frequent in the malnourished group, but the difference was not statistically significant.

Conclusions:

  • The study could not establish malnutrition as a direct cause of epilepsy in the studied population.
  • Other central nervous system damaging diseases confound the relationship between malnutrition and epilepsy.
  • Further research is needed to clarify the complex interplay of factors contributing to childhood epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313